hold

SINGAPORE (Nov 10): OCBC Investment Research is maintaining its “hold” call on Singapore Technologies Engineering with a fair value estimate of $3.41 following the group’s latest announcement of its 3Q17 financial results.

SINGAPORE (Nov 9): DBS Vickers Securities, CIMB Research, UOB Kay Hian and Maybank Kim Eng are maintaining their “hold” calls on Singapore Airlines (SIA) with higher price targets following the release of the carrier’s 2Q results on Tuesday.

SINGAPORE (Oct 23): RHB is maintaining its "neutral" call on Frasers Commercial Trust (FCOT) while Daiwa and OCBC reiterate their “hold” recommendations following last week's announcement of the trust's 4Q17 results, which came in l

SINGAPORE (Oct 11): Maybank Kim Eng is maintaining its “hold” call on Singapore Post (SingPost) with an unchanged price target of $1.22, pending clearer direction from the strategic review of the group’s business strategy.

SINGAPORE (Sept 26): OCBC Investment Research is keeping its “hold” recommendation on CapitaLand Commercial Trust (CCT) with a lower fair value estimate of $1.65 from $1.69 previously.

SINGAPORE (Sept 19): UOB Kay Hian is maintaining its “hold” call on Singapore Airlines group with a target price of $10.10, valuing the group’s core airlines operations at 0.7 times FY18 forward earnings.

SINGAPORE (July 26): UOB KayHian is keeping a “hold” call on Suntec REIT with a target price of $1.90 based on its dividend discount model (DDM), pending more details after the analyst briefing.

SINGAPORE (June 28): CIMB Research is downgrading SIA Engineering from "hold" to “reduce” with a lower price target of $3.86 in view of the stock’s expensive valuations and limited catalysts.

SINGAPORE (June 20): OCBC has downgraded Ascendas REIT to “hold” from “buy” with an unchanged fair value estimate of $2.66 given valuations are no longer valuable at this juncture.

SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong